Literature DB >> 8642868

Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.

E Rossi1, E Matutes, R Morilla, K Owusu-Ankomah, A M Heffernan, D Catovsky.   

Abstract

We have analyzed the expression of the zeta chain of the T cell receptor/CD3 complex and the co-stimulatory molecule CD28 by dual colour immunofluorescence on T lymphocytes from patients with B cell chronic lymphocytic leukemia (CLL). Zeta chain was significantly reduced on CD3-positive lymphocytes from 33 patients compared with normal controls (P<0.0001). The values were lower in stages B and C than in stage A. In five patients tested in partial remission the values were normal. CD28, investigated in CD3, CD4 and CD8 positive T cells from 18 CLL patients appeared to be reduced in the three subsets but more marked in CD8-positive lymphocytes. The loss of zeta chain and CD28 in a proportion of circulating T lymphocytes from CLL may underlie some of the known functional abnormalities of these cells and the immunodeficiency associated with the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642868

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).

Authors:  N Porakishvili; T Roschupkina; T Kalber; A P Jewell; K Patterson; K Yong; P M Lydyard
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy.

Authors:  Jaco A C van Bruggen; Anne W J Martens; Joseph A Fraietta; Tom Hofland; Sanne H Tonino; Eric Eldering; Mark-David Levin; Peter J Siska; Sanne Endstra; Jeffrey C Rathmell; Carl H June; David L Porter; J Joseph Melenhorst; Arnon P Kater; Gerritje J W van der Windt
Journal:  Blood       Date:  2019-05-10       Impact factor: 22.113

Review 3.  Immune reconstitution in chronic lymphocytic leukemia.

Authors:  John C Riches; Alan G Ramsay; John G Gribben
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

4.  Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patients.

Authors:  Yangqiu Li; Suxia Geng; Qingsong Yin; Shaohua Chen; Lijian Yang; Xiuli Wu; Bo Li; Xin Du; Christian A Schmidt; Grzegorz K Przybylski
Journal:  J Transl Med       Date:  2010-05-14       Impact factor: 5.531

Review 5.  Immunologic monitoring in chronic lymphocytic leukemia.

Authors:  William G Wierda
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 6.  Targeting inflammatory pathways in chronic lymphocytic leukemia.

Authors:  Uri Rozovski; Michael J Keating; Zeev Estrov
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-12       Impact factor: 6.312

Review 7.  Cell proliferation and apoptosis in the immune system in the elderly.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; M P Corsi; D Quaglino
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

8.  CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression.

Authors:  Jana M Schüle; Leif Bergkvist; Leif Håkansson; Bertil Gustafsson; Annika Håkansson
Journal:  J Transl Med       Date:  2004-12-21       Impact factor: 5.531

9.  Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma.

Authors:  Pei-Yu Huang; Shan-Shan Guo; Yu Zhang; Jia-Bin Lu; Qiu-Yan Chen; Lin-Quan Tang; Lu Zhang; Li-Ting Liu; Li Zhang; Hai-Qiang Mai
Journal:  Oncotarget       Date:  2016-03-15

10.  Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia.

Authors:  I Frydecka; A Kosmaczewska; D Bocko; L Ciszak; D Wolowiec; K Kuliczkowski; I Kochanowska
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.